Table 4.
Correlations of MRS measures with demographic and clinical variables within the patient group (N = 23)
| MRS metabolites | Age | Age of Onset | Y-BOCS | HAMA | HAMD-17 |
|---|---|---|---|---|---|
| GABA+ r(p) | −0.264 (0.224) | 0.307 (0.154) | −0.307 (0.154) | −0.033 (0.881) | 0.001 (0.995) |
| Glx r(p) | −0.144 (0.512) | 0.309 (0.151) | 0.007 (0.976) | 0.01 (0.964) | 0.071 (0.746) |
| GABA+/Glx Ratio r(p) | −0.122 (0.578) | −0.055 (0.805) | − 0.267 (0.218) | −0.071 (0.749) | − 0.145 (0.509) |
GABA gamma-aminobutyric acid, Glx glutamate-glutamine, HAMA Hamilton Anxiety Rating Scale,
HAMD-17 17-item Hamilton Depression Rating Scale, OCD obsessive-compulsive disorder